SCHEMBL4635730

SCHEMBL4635730

Cc1cn2ccccc2c1S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
KDM4E B2RXH2 6/20 0.43
HPGD P15428 5/20 0.43
CYP2C19 P33261 3/20 0.43
GAA P10253 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP3A4 P08684 2/20 0.42
MAPK1 P28482 1/20 0.42
ALDH3A1 P30838 2/20 0.41
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 4/20 0.40
CYP1A2 P05177 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
FLT1 P17948 1/20 0.39
FLT4 P35916 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4635342 0.86 HTR6 (0.42) ALDH1A1KDM4EHPGDGAACYP3A4
SCHEMBL9598092 0.86 RAPGEF4 (0.49) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL9599082 0.78 HTT (0.42) ALDH1A1CYP2C19CYP2C9CYP3A4MAPK1
SCHEMBL9598519 0.72 HRH3 (0.51) ALDH1A1MAPK1SMN1; SMN2HTT
SCHEMBL9599177 0.70 RAPGEF4 (0.41) ALDH1A1KDM4EHPGDCYP2C19GAA
SCHEMBL9566294 0.70 CA12 (0.44) ALDH1A1KDM4EHPGDGAANPC1
SCHEMBL2589947 0.70 MEN1 (0.46) ALDH1A1KDM4EHPGDCYP2C19GAA
SCHEMBL10040113 0.70 HTR6 (0.47) CYP2C9HTR6
SCHEMBL9598706 0.69 RAPGEF4 (0.39) KDM4EGAANPC1RAB9APKM
SCHEMBL4174907 0.69 RAPGEF4 (0.39) ALDH1A1KDM4EHPGDGAANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080306109-A1 Indolizine Derivatives as Ligands of the Crth2 Receptor ARGENTA DISCOVERY LIMITED (GB) 2008-12-11 US disclosed
EP-1931663-A1 IMDOLIZINE DERIVATIVES AS LIGANDS OF THE CRTH2 RECEPTOR Argenta Discovery Limited (GB) 2008-06-18 EP disclosed
WO-2007031747-A1 IMDOLIZINE DERIVATIVES AS LIGANDS OF THE CRTH2 RECEPTOR ARGENTA DISCOVERY LIMITED (GB) 2007-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306109-A1 Indolizine Derivatives as Ligands of the Crth2 Receptor HRH4, HRH2, HRH3 ALDH1A1 3463/4885KDM4E 4771/4885HPGD 782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.